Balance Sheet
Cash Flow Statement
Growth Metrics
Assets (QoQ)Assets Growth (1y)Assets Growth (3y)Cash & Equivalents (QoQ)Cash & Equivalents Growth (1y)Cash & Equivalents Growth (3y)Cash from Operations (QoQ)Cash from Operations Growth (1y)EBIT (QoQ)EBIT Growth (1y)EBT (QoQ)EBT Growth (1y)EPS (Basic) (QoQ)EPS (Basic) Growth (1y)EPS (Basic) Growth (3y)EPS (Weighted Average and Diluted) (QoQ)EPS (Weighted Average and Diluted) Growth (1y)EPS (Weighted Average and Diluted) Growth (3y)Enterprise Value (QoQ)Enterprise Value Growth (1y)Enterprise Value Growth (3y)Free Cash Flow (QoQ)Free Cash Flow Growth (1y)Interest Coverage Ratio (QoQ)Interest Coverage Ratio Growth (1y)Net Cash Flow (QoQ)Net Cash Flow Growth (1y)Net Income (QoQ)Net Income Growth (1y)Net Income towards Common Stockholders (QoQ)Net Income towards Common Stockholders Growth (1y)Operating Income (QoQ)Operating Income Growth (1y)Profit After Tax (QoQ)Profit After Tax Growth (1y)Profit After Tax Growth (3y)Return on Assets (QoQ)Return on Assets Growth (1y)Return on Capital Employed (QoQ)Return on Capital Employed Growth (1y)Return on Equity (QoQ)Return on Equity Growth (1y)Share-based Compensation (QoQ)Shareholder's Equity (QoQ)Shareholder's Equity Growth (1y)Shareholder's Equity Growth (3y)
Income Statement
Others
Ratios

Adaptin Bio (APTN) Cash & Equivalents Growth (1y) (2023 - 2026)

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -87.31%
Dec 31, 2025 1,247.14%
Sep 30, 2025 179,741.30%
Jun 30, 2025 5,584.38%
Mar 31, 2025 46,830.80%
Dec 31, 2024 616.98%
Sep 30, 2024 -15.26%
Jun 30, 2024 4,655.20%
Dec 31, 2023 850.80%